Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Parkinson Disease 4, Autosomal Dominant Lewy Body × Platinum Compounds × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 18 Lung Neoplasms 3 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2 Esophageal Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Retinoblastoma 1 Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC) 1 Recurrence 1 Ovarian Neoplasms 1 Ovarian Cancer Recurrent 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 NSCLC 1 Melanoma 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Bronchogenic 1 Bronchial Neoplasms 1

Interventions

pembrolizumab 104 Cisplatin 28 lenvatinib 26 Paclitaxel 24 Carboplatin 24 Pemetrexed 13 Gemcitabine 9 Docetaxel 9 Saline Solution 8 Fluorouracil 8 Capecitabine 7 olaparib 6 Oxaliplatin 6 Bevacizumab 6 Albumin-Bound Paclitaxel 6 epacadostat 5 Etoposide 5 Cetuximab 5 belzutifan 4 Leucovorin 4 130-nm albumin-bound paclitaxel 4 patritumab deruxtecan 3 enzalutamide 3 durvalumab 3 Glucose 3 Dexamethasone 3 Acetaminophen 3 trifluridine tipiracil drug combination 2 regorafenib 2 liposomal doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡